IGH/FGFR3 Gene Fusion Probe Detection Kit (IVD)

IGH/FGFR3 Gene Fusion Probe Detection Kit (IVD)

The FGFR proteins are involved in a wide array of pathways known to play a significant role in cancer. Activation of these receptors can lead to activation of the RAS-MAPK pathway and the PI3K-AKT pathway, among others. The mechanisms by which FGFR can be misregulated vary between cancers. Amplification of the receptors has been observed in lung and breast cancers, coding mutations and deletions have been seen in many cancers, and more recently, FGFR fusions that lead to pathway activation have been demonstrated to have oncogenic potential across multiple cancer types. The targeted therapeutics ponatinib, dovitinib and pazopanib have seen success in treating over-active FGFR signaling, prompting use of diagnostic sequencing targeting the FGFR genes, especially in lung cancer patients.